Study in Parkinson's Disease Patients With Dyskinesia With Combinations of JM-010 and Its Individual Components

Summary

This is a two-part, double-blind, placebo-controlled, randomized, multicenter Phase 2 clinical trial of JM-010 in patients with Parkinson's Disease.

Timeline

Start

2021-04-28

Primary completion

2024-02-14

Completion

2024-02-14

Outcome

Outcome not reported

Stopped (Business): “Business reasons”

Drugs

Indications